Sandoz announced sales results for the first quarter 2024. For the period, the company announced net sales of USD 2,492 million against USD 2,384 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.65 CHF | +1.09% | -0.25% | +16.96% |
May. 22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
May. 22 | Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.96% | 15.04B | |
+16.93% | 42.79B | |
+22.25% | 22.81B | |
+18.51% | 14.49B | |
+51.63% | 12.65B | |
-0.05% | 6.79B | |
-11.65% | 6.74B | |
-8.87% | 5.73B | |
+14.27% | 5.47B | |
+6.91% | 4.76B |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Sandoz Announces Sales Results for the First Quarter 2024